Skip to main content
Top
Published in: Clinical and Experimental Medicine 1/2016

01-02-2016 | Original Article

Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use

Authors: Tomomitsu Tahara, Tomoyuki Shibata, Tomohiko Kawamura, Takamitsu Ishizuka, Masaaki Okubo, Mitsuo Nagasaka, Yoshihito Nakagawa, Tomiyasu Arisawa, Naoki Ohmiya, Ichiro Hirata

Published in: Clinical and Experimental Medicine | Issue 1/2016

Login to get access

Abstract

Telomere shortening occurs with human aging in many organs and tissues and is accelerated by rapid cell turnover and oxidative injury. We measured average telomere length using quantitative real-time PCR in non-neoplastic gastric mucosa and assessed its relationship to H. pylori-related gastritis, DNA methylation, ulcer disease, and nonsteroidal anti-inflammatory drug (NSAID) usage. Gastric biopsies were obtained from 151 cancer-free subjects including 49 chronic NSAID users and 102 nonusers. Relative telomere length in genomic DNA was measured by real-time PCR. H. pylori infection status, histological severity of gastritis, and serum pepsinogens (PGs) were also investigated. E-cadherin (CDH1) methylation status was determined by methylation-specific PCR (MSP). Average relative telomere length of H. pylori-infected subjects was significantly shortened when compared to H. pylori-negative subjects (p = 0.002) and was closely associated with all histological parameter of gastritis (all p values <0.01) and CDH1 methylation (p = 0.0002). In H. pylori-negative subjects, NSAID users presented significantly shorter telomere length than nonusers (p = 0.028). Shorter telomere length was observed in duodenal and gastric ulcer patients compared with non-ulcer subjects among NSAID users. Telomere shortening is closely associated with severity of H. pylori-induced gastritis and CDH1 methylation status. Also, telomere shortening is accelerated by NSAID usage especially in H. pylori-negative subjects.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Lange T. The protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–10.CrossRefPubMed de Lange T. The protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–10.CrossRefPubMed
2.
go back to reference Jennings BJ, Ozanne SE, Hales CN. Nutrition, oxidative damage, telomere shortening, and cellular senescence: individual or connected agents of aging? Mol Genet Metab. 2000;71:32–42.CrossRefPubMed Jennings BJ, Ozanne SE, Hales CN. Nutrition, oxidative damage, telomere shortening, and cellular senescence: individual or connected agents of aging? Mol Genet Metab. 2000;71:32–42.CrossRefPubMed
3.
go back to reference von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339–44.CrossRef von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27:339–44.CrossRef
4.
go back to reference Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366:662–4.CrossRefPubMed Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366:662–4.CrossRefPubMed
5.
go back to reference Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95:1211–8.CrossRefPubMed Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95:1211–8.CrossRefPubMed
6.
go back to reference Schönland SO, Lopez C, Widmann T, et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA. 2003;100:13471–6.CrossRefPubMedPubMedCentral Schönland SO, Lopez C, Widmann T, et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA. 2003;100:13471–6.CrossRefPubMedPubMedCentral
7.
go back to reference Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–60.CrossRefPubMed Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345:458–60.CrossRefPubMed
8.
go back to reference Vulliamy T, Marrone A, Dokal I, et al. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002;359:2168–70.CrossRefPubMed Vulliamy T, Marrone A, Dokal I, et al. Association between aplastic anaemia and mutations in telomerase RNA. Lancet. 2002;359:2168–70.CrossRefPubMed
9.
10.
11.
go back to reference Hande MP, Samper E, Lansdorp P, et al. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol. 1999;144:589–601.CrossRefPubMedPubMedCentral Hande MP, Samper E, Lansdorp P, et al. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol. 1999;144:589–601.CrossRefPubMedPubMedCentral
12.
go back to reference Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.CrossRefPubMed Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.CrossRefPubMed
14.
go back to reference Cheung AL, Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci. 2008;13:2075–90.CrossRefPubMed Cheung AL, Deng W. Telomere dysfunction, genome instability and cancer. Front Biosci. 2008;13:2075–90.CrossRefPubMed
15.
go back to reference Murnane JP. Telomeres and chromosome instability. DNA Repair (Amst). 2006;5:1082–92.CrossRef Murnane JP. Telomeres and chromosome instability. DNA Repair (Amst). 2006;5:1082–92.CrossRef
16.
go back to reference Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am. 1993;22:89–104.PubMed Parsonnet J. Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am. 1993;22:89–104.PubMed
17.
go back to reference Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37.CrossRefPubMed Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37.CrossRefPubMed
18.
go back to reference Aida J, Izumiyama-Shimomura N, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38:1192–200.CrossRefPubMed Aida J, Izumiyama-Shimomura N, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38:1192–200.CrossRefPubMed
19.
go back to reference Kuniyasu H, Kitadai Y, Mieno H, et al. Helicobacter pylori infection is closely associated with telomere reduction in gastric mucosa. Oncology. 2003;65:275–82.CrossRefPubMed Kuniyasu H, Kitadai Y, Mieno H, et al. Helicobacter pylori infection is closely associated with telomere reduction in gastric mucosa. Oncology. 2003;65:275–82.CrossRefPubMed
20.
go back to reference Maruyama Y, Hanai H, Fujita M, et al. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol. 1997;27:216–20.CrossRefPubMed Maruyama Y, Hanai H, Fujita M, et al. Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol. 1997;27:216–20.CrossRefPubMed
21.
go back to reference Maruyama Y, Hanai H, Kaneko E. Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach. Nippon Rinsho. 1998;56:1186–9.PubMed Maruyama Y, Hanai H, Kaneko E. Telomere length and telomerase activity in intestinal metaplasia, adenoma and well differentiated adenocarcinoma of the stomach. Nippon Rinsho. 1998;56:1186–9.PubMed
22.
go back to reference Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 1984;77:19–24.CrossRefPubMed Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 1984;77:19–24.CrossRefPubMed
23.
go back to reference Wang JY, Yamasaki S, Takeuchi K, et al. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology. 1989;96:393–402.PubMed Wang JY, Yamasaki S, Takeuchi K, et al. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology. 1989;96:393–402.PubMed
24.
go back to reference Konturek PK, Brzozowski T, Konturek SJ, et al. Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology. 1990;99:1607–15.PubMed Konturek PK, Brzozowski T, Konturek SJ, et al. Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology. 1990;99:1607–15.PubMed
25.
go back to reference Ukawa H, Yamakuni H, Kato S, et al. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci. 1998;43:2003–11.CrossRefPubMed Ukawa H, Yamakuni H, Kato S, et al. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig Dis Sci. 1998;43:2003–11.CrossRefPubMed
26.
go back to reference Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94–8.PubMed Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94–8.PubMed
28.
go back to reference Tahara T, Arisawa T, Shibata T, et al. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan. Int J Mol Med. 2007;20:373–8.PubMed Tahara T, Arisawa T, Shibata T, et al. Association between genetic polymorphisms in the cyclooxygenase-1 gene promoter and peptic ulcers in Japan. Int J Mol Med. 2007;20:373–8.PubMed
29.
go back to reference Shiroeda H, Tahara T, Shibata T, et al. Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases. Int J Mol Med. 2010;26:707–11.PubMed Shiroeda H, Tahara T, Shibata T, et al. Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases. Int J Mol Med. 2010;26:707–11.PubMed
30.
go back to reference Tahara T, Arisawa T, Shibata T, et al. Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects. Dig Dis Sci. 2009;54:1247–52.CrossRefPubMed Tahara T, Arisawa T, Shibata T, et al. Effect of RANTES promoter genotype on the severity of intestinal metaplasia in Helicobacter pylori-infected Japanese subjects. Dig Dis Sci. 2009;54:1247–52.CrossRefPubMed
31.
go back to reference Tahara T, Shibata T, Nakamura M, et al. Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci. 2010;55:54–9.CrossRefPubMed Tahara T, Shibata T, Nakamura M, et al. Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa. Dig Dis Sci. 2010;55:54–9.CrossRefPubMed
32.
go back to reference Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed
33.
go back to reference Kekki M, Samloff IM, Varis K, et al. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol suppl. 1991;186:109–16.CrossRefPubMed Kekki M, Samloff IM, Varis K, et al. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol suppl. 1991;186:109–16.CrossRefPubMed
34.
go back to reference Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.PubMed Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760–6.PubMed
35.
go back to reference Yamamoto E, Toyota M, Suzuki H, et al. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol Biomarkers Prev. 2008;17:2555–64.CrossRefPubMed Yamamoto E, Toyota M, Suzuki H, et al. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol Biomarkers Prev. 2008;17:2555–64.CrossRefPubMed
36.
go back to reference McGrath M, Wong JY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:815–9.CrossRefPubMed McGrath M, Wong JY, Michaud D, et al. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:815–9.CrossRefPubMed
37.
go back to reference Risques RA, Lai LA, Himmetoglu C, et al. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res. 2011;71:1669–79.CrossRefPubMedPubMedCentral Risques RA, Lai LA, Himmetoglu C, et al. Ulcerative colitis-associated colorectal cancer arises in a field of short telomeres, senescence, and inflammation. Cancer Res. 2011;71:1669–79.CrossRefPubMedPubMedCentral
38.
go back to reference Cheng Y, Desreumaux P. 5-Aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol. 2005;11:309–14.CrossRefPubMedPubMedCentral Cheng Y, Desreumaux P. 5-Aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease. World J Gastroenterol. 2005;11:309–14.CrossRefPubMedPubMedCentral
39.
go back to reference Shen H, Sun WH, Xue QP, et al. Influences of Helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro. J Gastroenterol Hepatol. 2006;21:754–8.CrossRefPubMed Shen H, Sun WH, Xue QP, et al. Influences of Helicobacter pylori on cyclooxygenase-2 expression and prostaglandinE2 synthesis in rat gastric epithelial cells in vitro. J Gastroenterol Hepatol. 2006;21:754–8.CrossRefPubMed
40.
go back to reference Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.CrossRefPubMed Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.CrossRefPubMed
41.
go back to reference Perri F, Cotugno R, Piepoli A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol. 2007;102:1361–71.CrossRefPubMed Perri F, Cotugno R, Piepoli A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol. 2007;102:1361–71.CrossRefPubMed
42.
go back to reference Aslan R, Bektas A, Bedir A, et al. Helicobacter pylori eradication increases telomere length in gastric mucosa. Hepatogastroenterology. 2013;60:601–4.PubMed Aslan R, Bektas A, Bedir A, et al. Helicobacter pylori eradication increases telomere length in gastric mucosa. Hepatogastroenterology. 2013;60:601–4.PubMed
43.
go back to reference Zhang ZX, Wang Y, Tao ZZ, et al. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines. Cancer Biother Radiopharm. 2014;29:289–94.CrossRefPubMed Zhang ZX, Wang Y, Tao ZZ, et al. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines. Cancer Biother Radiopharm. 2014;29:289–94.CrossRefPubMed
44.
go back to reference Tomisato W, Tsutsumi S, Hoshino T, et al. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 2004;67:575–85.CrossRefPubMed Tomisato W, Tsutsumi S, Hoshino T, et al. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 2004;67:575–85.CrossRefPubMed
45.
go back to reference Bindu S, Mazumder S, Dey S, et al. Non-steroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-κB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against non-steroidal anti-inflammatory drug. Free Radic Biol Med. 2003 [Epub ahead of print]. Bindu S, Mazumder S, Dey S, et al. Non-steroidal anti-inflammatory drug induces proinflammatory damage in gastric mucosa through NF-κB activation and neutrophil infiltration: anti-inflammatory role of heme oxygenase-1 against non-steroidal anti-inflammatory drug. Free Radic Biol Med. 2003 [Epub ahead of print].
Metadata
Title
Telomere length in non-neoplastic gastric mucosa and its relationship to H. pylori infection, degree of gastritis, and NSAID use
Authors
Tomomitsu Tahara
Tomoyuki Shibata
Tomohiko Kawamura
Takamitsu Ishizuka
Masaaki Okubo
Mitsuo Nagasaka
Yoshihito Nakagawa
Tomiyasu Arisawa
Naoki Ohmiya
Ichiro Hirata
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 1/2016
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-014-0335-0

Other articles of this Issue 1/2016

Clinical and Experimental Medicine 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.